Search

everythinglearnresearchcommunity

for

Search:↓

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Obese and lean women with PCOS have different symptoms and need different treatments.

People with male pattern baldness are more likely to have metabolic syndrome.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Early-onset AGA shows different hair and metabolic characteristics compared to normal-onset AGA.

Many women with postadolescent acne also have hormonal imbalances and are at higher risk for metabolic issues.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

People with early-onset hair loss have higher risk of heart issues, so early screening is important.

There's no clear link between female pattern hair loss, insulin resistance, and metabolic syndrome.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Melatonin improved mental health and metabolism in women with PCOS.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Finasteride doesn't affect omeprazole metabolism in Japanese people.

PCOS involves hormonal and metabolic issues, increasing risks for diabetes and heart disease, and requires lifestyle changes and medication for management.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Inhibiting 5α-reductase increases progesterone levels in late pregnant mares.

Nearly half of women with PCOS have metabolic syndrome, and lifestyle changes are crucial to prevent complications.

High chromogranin A levels are linked to obesity and inflammation in polycystic ovary syndrome.

The method reliably profiles eicosanoids and shows epitestosterone reduces their levels, similar to common anti-inflammatory drugs.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

Targeting glycolysis may help treat PCOS by improving insulin sensitivity and ovarian function.

Vitamin D may help regulate cholesterol and influence prostate cancer development.

High 1-hour plasma glucose in PCOS increases risks of metabolic issues and gestational diabetes.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

The research identified genes and non-coding RNAs in cells that could be affected by testosterone, which may help understand hair loss and prostate cancer.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.